Registered business in FR. Official registry identity, company-size evidence and a public indicative value curve on one indexed company profile.
A broad indicative range based on official company-size information and governed sector comparables. It is not a company-specific appraisal, market value, asking price, or offer.
Based on official company-size informationOne public valuation range is currently available. A future eligible filing can extend this into a trend.
The historical value curve is public. Create a free account for the future five-year growth outlook, the insights behind it, and concrete action points that can increase this company’s value.
Free account · private workspace
Each step adds evidence that narrows the range. Public filings are a starting point. Connected accounts, owner context and method review make the valuation useful for real decisions: selling, financing or transferring.
Own this company? Claim and manage the profileThis broad public curve is a starting point based on governed sector or size evidence. Create a free account to refine it with verified company data and see the five-year outlook with concrete action points.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
BRIDGEBIO PHARMA FRANCE SAS, a business in NACE sector 82.99, is registered at an address in France. The company was founded in 2026, incorporated as a 5710.
BRIDGEBIO PHARMA FRANCE SAS is listed in French National Business Register (RNE/INPI) under registry number 101342970.
BRIDGEBIO PHARMA FRANCE SAS's registered activity maps to NACE 82.99; public financial-account availability varies by registry and company type.
BRIDGEBIO PHARMA FRANCE SAS's public curve combines official company-size information with sector multiples. Its centre line is only the arithmetic middle of the band and is not a sale price, offer, or recommendation.
It is not a midpoint, asking price, offer, or recommendation; owner or advisor data is required for a company-specific appraisal.
BRIDGEBIO PHARMA FRANCE SAS was founded in 2026 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
BRIDGEBIO PHARMA FRANCE SAS is registered under NACE 82.99: NACE 82.99. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for BRIDGEBIO PHARMA FRANCE SAS may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
